Skip to main content
    H

    Hyperfine Inc (HYPR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.61
    -0.02 (-3.05%)

    Market Cap: $66.74M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Hyperfine Inc (HYPR) Earnings: Report Dates and Results

    Updated Nov 9, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Sep 30, 2026, Hyperfine reported EPS of -$0.07, above the -$0.08 estimate. It beat the EPS estimate in 2 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    42%(8/19)
    Avg Surprise
    -2.14%
    Streak
    1 Q

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$0.08
    Range-$0.08 - -$0.07
    6 analysts
    Revenue Consensus
    $6.89M
    Range$6.08M - $7.71M
    6 analysts
    Report date not yet scheduledPeriod ending Mar 31, 2027
    EPS Consensus-$0.08
    Range-$0.08 - -$0.08
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$0.00n/a
    7d ago-$0.080.0%
    Current-$0.08
    Revenue Consensus
    $5.00M
    Range$4.80M - $5.20M
    2 analysts

    Next Report

    HYPR's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.

    HYPR Earnings Call

    The latest HYPR earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 19 quarters below that had an estimate, HYPR beat 8, missed 4 and matched 7. Revenue for the quarter ended Sep 30, 2026 was $5.96M, up 73.3% from $3.44M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.07-$0.08-$0.09 - -$0.08+12.50%BeatN/A32 up, 0 downNov 9, 2026$5.96M
    Jun 30, 2026-$0.09-$0.09-$0.09 - -$0.090.00%In lineN/A20 up, 0 downAug 6, 2026$3.90M
    Mar 31, 2026-$0.09-$0.11N/A+19.73%BeatN/A20 up, 0 downMay 12, 2026$3.90M
    Dec 31, 2025-$0.08-$0.08-$0.08 - -$0.080.00%In lineN/A21 up, 0 downMar 18, 2026$5.29M
    Sep 30, 2025-$0.14-$0.10-$0.11 - -$0.10-40.00%MissN/A21 up, 0 downNov 13, 2025$3.44M
    Jun 30, 2025-$0.12-$0.12-$0.12 - -$0.120.00%In lineN/A30 up, 2 downAug 13, 2025$2.70M
    Mar 31, 2025-$0.12-$0.12-$0.12 - -$0.110.00%In lineN/A40 up, 0 downMay 13, 2025$2.14M
    Dec 31, 2024-$0.14-$0.14-$0.15 - -$0.120.00%In lineN/A20 up, 0 downMar 17, 2025$2.32M
    Sep 30, 2024-$0.14-$0.14-$0.14 - -$0.140.00%In lineN/A30 up, 0 downNov 12, 2024$3.64M
    Jun 30, 2024-$0.14-$0.14-$0.15 - -$0.130.00%In lineN/A30 up, 0 downAug 8, 2024$3.63M
    Mar 31, 2024-$0.14-$0.15-$0.16 - -$0.14+6.67%BeatN/A30 up, 0 downMay 13, 2024$3.29M
    Dec 31, 2023-$0.15-$0.18-$0.20 - -$0.16+16.67%BeatN/A30 up, 0 downMar 21, 2024$2.69M
    Sep 30, 2023-$0.15-$0.16-$0.17 - -$0.15+6.25%BeatN/A20 up, 0 downNov 9, 2023$2.33M
    Jun 30, 2023-$0.15-$0.16-$0.17 - -$0.16+6.25%BeatN/A20 up, 0 downAug 14, 2023$3.38M
    Mar 31, 2023-$0.17-$0.13-$0.16 - -$0.11-30.77%MissN/A30 up, 0 downMay 11, 2023$2.63M
    Dec 31, 2022-$0.19-$0.25-$0.25 - -$0.20+24.00%BeatN/A30 up, 0 downMar 21, 2023$1.42M
    Sep 30, 2022-$0.19-$0.26-$0.26 - -$0.25+26.92%BeatN/A30 up, 0 downNov 10, 2022$2.35M
    Jun 30, 2022-$0.33-$0.26N/A-26.92%MissN/A10 up, 0 downAug 10, 2022$1.53M
    Mar 31, 2022-$0.34-$0.21-$0.21 - -$0.21-61.90%MissN/A10 up, 0 downMay 11, 2022$1.51M
    Dec 31, 2021-$0.37N/AN/AN/AN/AN/AN/AN/AMar 23, 2022$436000
    Sep 30, 2021-$0.03N/AN/AN/AN/AN/AN/AN/ANov 18, 2021$371000
    Jun 30, 2021-$0.05N/AN/AN/AN/AN/AN/AN/AAug 18, 2021$358000
    Mar 31, 2021-$0.01N/AN/AN/AN/AN/AN/AN/AMay 17, 2021$331000
    Last 23 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.46, after -$0.56 the year before. It was -$0.46 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.46N/A
    Dec 31, 2024-$0.56N/A
    Dec 31, 2023-$0.62N/A
    Dec 31, 2022-$1.05N/A
    Dec 31, 2021-$0.46N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 6,400 words across 8 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20266,3648
    2026Q2Jun 30, 20263,4486
    2026Q1Mar 31, 20264,1747
    2025Q4Dec 31, 20255,0116
    2025Q3Sep 30, 20254,4937
    2025Q2Jun 30, 20255,7897
    2025Q1Mar 31, 20254,8087
    2024Q4Dec 31, 20245,1677

    2026Q3 Earnings Call

    Opening remarks

    Webb Campbell Investor Relations Thank you for joining today's call. Earlier today, Hyperfine, Inc. released financial results for the quarter ended September 30, 2026. A copy of the press release is available on the company's website as well as sec.gov. Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of the federal securities law and made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements. All forward-looking statements, including, without limitation, those relating to our operating trends and future financial performance, expense management, market opportunity, commercial and international expansion, regulatory approvals and product development are based upon our current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the Risk Factors section of our latest periodic filings with the Securities and Exchange Commission. This conference call contains time-sensitive information and is accurate only as of today's live broadcast. Hyperfine, Inc. disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise. With that, I will turn the call over to Maria Sainz, President and Chief Executive Officer.

    Maria Sainz President and Chief Executive Officer Good afternoon, and thank you for joining us. On the call with me today is the Chief Administrative Officer and Chief Financial Officer, Brett Hale. The financial results in the third quarter were the strongest in Hyperfine's history. We delivered records across the P&L, revenue, gross profit and gross margin, along with the narrowest operating loss and our lowest quarterly net cash burn. This is not just a great quarter; it marks the beginning of a new trajectory. Revenue was a record $6 million, up 53% sequentially and 73% year-over-year. Gross margin was a record 56.7%. Net cash burn fell 29% sequentially to $5.6 million, and for the first time, quarterly revenue exceeded net cash burn. Brett will walk you through the details. I want to step back and reflect on where we are, who we are, and the significant opportunity in front of us to advance brain health and drive meaningful long-term value for our shareholders.

    Frequently Asked Questions About HYPR

    Did HYPR beat earnings estimates last quarter?

    Yes. Hyperfine reported EPS of -$0.07 for the quarter ended Sep 30, 2026, above the -$0.08 estimate, a 12.50% surprise.

    What EPS do analysts expect from HYPR next quarter?

    The consensus EPS estimate for Hyperfine for the quarter ending Dec 31, 2026 is -$0.08 from 6 analysts, with estimates from -$0.08 to -$0.07.

    How often does HYPR beat earnings estimates?

    Hyperfine beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -0.97%.